Improvement of cardiac function by placenta-derived mesenchymal stem cells does not require permanent engraftment and is independent of the insulin signaling pathway

INTRODUCTION: The objective of this work was to evaluate the efficacy of placenta-derived mesenchymal stem cell (MSC) therapy in a mouse model of myocardial infarction (MI). Since MSCs can be obtained from two different regions of the human term placenta (chorionic plate or villi), cells obtained fr...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Stem Cell Res Ther
Main Authors: Passipieri, Juliana A, Kasai-Brunswick, Tais H, Suhett, Grazielle, Martins, Andreza B, Brasil, Guilherme V, Campos, Dilza B, Rocha, Nazareth N, Ramos, Isalira P, Mello, Debora B, Rodrigues, Deivid C, Christie, Beatriz B, Silva-Mendes, Bernardo J, Balduíno, Alex, Sá, Renato M, Lopes, Laudelino M, Goldenberg, Regina C, Campos de Carvalho, Antonio C, Carvalho, Adriana B
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2014
נושאים:
Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4354978/
https://ncbi.nlm.nih.gov/pubmed/25145631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/scrt490
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים